Production (Stage)
Twist Bioscience Corporation
TWST
$28.26
$0.100.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 347.68M | 330.19M | 312.97M | 295.21M | 277.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 347.68M | 330.19M | 312.97M | 295.21M | 277.49M |
| Cost of Revenue | 185.31M | 182.96M | 179.63M | 175.57M | 171.23M |
| Gross Profit | 162.37M | 147.23M | 133.35M | 119.64M | 106.26M |
| SG&A Expenses | 229.78M | 221.74M | 218.40M | 212.65M | 201.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 503.92M | 493.76M | 488.88M | 481.68M | 468.66M |
| Operating Income | -156.24M | -163.57M | -175.90M | -186.47M | -191.17M |
| Income Before Tax | -190.78M | -196.78M | -208.17M | -219.88M | -191.27M |
| Income Tax Expenses | 367.00K | 537.00K | 560.00K | 434.00K | 865.00K |
| Earnings from Continuing Operations | -191.15 | -197.31 | -208.73 | -220.31 | -192.14 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -191.15M | -197.31M | -208.73M | -220.31M | -192.14M |
| EBIT | -156.24M | -163.57M | -175.90M | -186.47M | -191.17M |
| EBITDA | -131.10M | -136.53M | -147.07M | -154.10M | -158.61M |
| EPS Basic | -3.26 | -3.38 | -3.60 | -3.81 | -3.35 |
| Normalized Basic EPS | -1.55 | -1.63 | -1.76 | -1.86 | -1.91 |
| EPS Diluted | -3.26 | -3.38 | -3.60 | -3.81 | -3.35 |
| Normalized Diluted EPS | -1.55 | -1.63 | -1.76 | -1.86 | -1.91 |
| Average Basic Shares Outstanding | 235.51M | 233.64M | 231.98M | 230.70M | 229.60M |
| Average Diluted Shares Outstanding | 235.51M | 233.64M | 231.98M | 230.70M | 229.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |